About Us
2020 Elabscience customer high score literature TOP10
Source: Elabscience®Published: Feb 23,2021
According to incomplete statistics, the total number of SCI papers cited by Elabscience®products has reached 6000, and the total IF 12595.468, the highest IF is as high as 42.778.
In recent years, the number of citations of Elabscience®product papers has increased significantly year by year, and has been recognized by more and more customers. With high-quality and reliable quality, it has helped customers publish high-scoring documents in top journals such as Nature, Cell, Advanced Functional Materials, etc. Elabscience®is also much honored to be able to achieve significant breakthrough research assistance for global researchers!
SCI article impact factor (IF)
2020 literature TOP10
In 2020, 1123 new articles published by Elabscience®customers, with a total IF of 3,381.746. Next, let us review the TOP 10 high-scoring documents of Elabscience®2020, and count the highlights of Elabscience®customers.
-
TOP1
- Title: DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25
- Abstract: The new mechanism of DNA of Neutrophil extracellular traps promoting cancer metastasis
- Journal: Nature
- IF: 42.778
- First author: Sun Yat-Sen University, Guangzhou, China
- Elabscience®Products Cited: 8-OHdG (E-EL-0028)
-
TOP2
- Title: Targeting Mitochondria-Located circRNA SCAR Alleviates NASH via Reducing mROS Output
- Abstract: A mitochondrial circRNA SCAR alleviates NASH via reducing mROS output
- Journal: Cell
- IF: 38.637
- First author: Sun Yat-Sen University, Guangzhou, China
- Elabscience®Products Cited: Human IL-1β (E-EL-H0149),Human TNF-α (E-EL-H0109),Human IL-8 (E-EL-H6008)
-
TOP3
- Title: Dual-Locking Nanoparticles Disrupt the PD-1/PD-L1 Pathway for Efficient Cancer Immunotherapy
- Abstract: DLNP will become a potential universal platform for safe and effective cancer immunotherapy
- Journal: Advanced Materials
- IF: 27.398
- First author: Nankai University, Tianjin, China
- Elabscience®Products Cited: TGF-β1 (E-EL-0162), Mouse IFN-γ (E-EL-M0048), Mouse TNF-α (E-EL-M0049), Mouse IL-2 (E-EL-M0042), Mouse IL-12 (E-EL-M0726)
-
TOP4
- Title: The 10q26 Risk Haplotype of Age-Related Macular Degeneration Aggravates Subretinal Inflammation by Impairing Monocyte Elimination
- Abstract: CD47 agonists and OPN inhibitors can be a potential treatment of AMD
- Journal: Immunity
- IF: 22.553
- First author: Sorbonne Université, France
- Elabscience®Products Cited: Human HTRA1 (E-EL-H0423)
-
TOP5
- Title: Interneuron Accumulation of Phosphorylated Tau Impairs Adult Hippocampal Neurogenesis by Suppressing GABAergic Transmission
- Abstract: Abnormal accumulation of pTau protein destroys the microenvironment of hippocampal neurogenesis
- Journal: Cell Stem Cell
- IF: 20.86
- First author: Huazhong University of Science and Technology
- Elabscience®Products Cited: Human Aβ1-40 (E-EL-H0542), Human Aβ1-42 (E-EL-H0543)
-
TOP6
- Title: METTL3-mediated m6A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance
- Abstract: The biological function and clinical significance of METTL3 in gastric cancer
- Journal: Gut
- IF: 19.819
- First author: Nanjing University Medical School, Nanjing, China
- Elabscience®Products Cited: Human HDGF (E-EL-H5651)
-
TOP7
- Title: NIR/ROS-Responsive Black Phosphorus QD Vesicles as Immunoadjuvant Carrier for Specific Cancer Photodynamic Immunotherapy
- Abstract: The developed ROS-sensitive BPNVs encapsulate the immunoadjuvant CpG for anticancer photodynamic immunotherapy
- Journal: Advanced Functional Materials
- IF: 16.836
- First author: Fuzhou University, Fuzhou, China
- Elabscience®Products Cited: Mouse IL-6 (E-EL-M0044), Mouse TNF-α (E-EL-M0049), Mouse IL-12 (E-EL-M0726)
-
TOP8
- Title: Transformable Nanoparticle-Enabled Synergistic Elicitation and Promotion of Immunogenic Cell Death for Triple-Negative Breast Cancer Immunotherapy
- Abstract: Novel nanoparticles synergistically stimulate and promote immunogenic cell death in triple-negative breast cancer immunotherapy
- Journal: Advanced Functional Materials
- IF: 16.836
- First author: HuaZhong University of Science and Technology, Wuhan, China
- Elabscience®Products Cited: Mouse IL-6 (E-EL-H1554)
-
TOP9
- Title: Nuclear Receptor PXR Targets AKR1B7 to Protect Mitochondrial Metabolism and Renal Function in AKI
- Abstract: Nuclear Receptor PXR Targets AKR1B7 to Protect Mitochondrial Metabolism and Renal Function in AKI
- Journal: Sci Transl Med
- IF: 16.304
- First author: Nanjing Medical University
- Elabscience®Products Cited: Mouse IL-6 (E-EL-M0044), Mouse TNF-α (E-EL-M0049)
-
TOP10
- Title: Smart nano-sacrificial layer on the bone surface prevents osteoporosis through acid-base neutralization regulated biocascade effects
- Abstract: Nanomaterial induce chemical regulation of biological cascade effects to prevent osteoporosis
- Journal: Journal of the American chemical society
- IF: 14.612
-
First author: Zhejiang University, China
Key Laboratory of Musculoskeletal System Degeneration and Regeneration Translational Research of Zhejiang Province, China - Elabscience®Products Cited: Mouse PⅠNP (E-EL-M0233), Mouse β-CTx (E-EL-M0372) ,Mouse ACP5 (E-EL-M1116)
- View more>>
Elabscience®products are worthy of your trust
-
ELISA kit
11 years of focus on R & D and production of ELISA
Excellent quality, good feedback from customers
Covering 11 species including human, mouse, rat, monkey, etc., with a total of more than 1,600 products
The number of references is high, with over 6000 SCI papers
Professional technical support service
-
Antibodies
Reactivity: antibodies specifically recognize proteins from different species
Application: The possibility that antibodies can be applied to specific experiments
Clonality: Rabbit polyclonal antibodies have stronger ability to recognize antigens, and mouse monoclonal antibodies have better specificity
Clonality: Rabbit polyclonal antibodies have stronger ability to recognize antigens, and mouse monoclonal antibodies have better specificity
Cross-reaction: High-quality antibodies do not cross-react with other homologous proteins
Cross-reaction: High-quality antibodies do not cross-react with other homologous proteins
》Elabscience®antibody makes your scientific research more efficient!
In the future, we will continue to improve the product literature database, organize relevant literature information, and continue to track and report the latest developments in related literature. Elabscience will provide the most trustworthy products and services to help your scientific research.
You are invited to join the Elabscience®high-scoring literature group and participate in the "Distribute literature, get rewards" activity. For more details, please click: 2021 Paper Award Program